Whole-Tumor Quantitative Apparent Diffusion Coefficient Histogram and Texture Analysis to Predict Gleason Score Upgrading in Intermediate-Risk 3 + 4 = 7 Prostate Cancer.
暂无分享,去创建一个
Nicola Schieda | R. Thornhill | C. Lim | N. Schieda | T. Flood | R. Rozenberg | Shaheed W. Hakim | Rebecca E Thornhill | Trevor A Flood | Christopher Lim | Shaheed W Hakim | Radu Rozenberg
[1] A. Evans,et al. Prostate tissue composition and MR measurements: investigating the relationships between ADC, T2, K(trans), v(e), and corresponding histologic features. , 2010, Radiology.
[2] H. Hricak,et al. Haralick texture analysis of prostate MRI: utility for differentiating non-cancerous prostate from prostate cancer and differentiating prostate cancers with different Gleason scores , 2015, European Radiology.
[3] K. Markou,et al. National Comprehensive Cancer Network (NCCN) Head and Neck Cancers NCCN Clinical Practice Guidelines in Oncology . 2010. , 2011 .
[4] Robert M. Haralick,et al. Textural Features for Image Classification , 1973, IEEE Trans. Syst. Man Cybern..
[5] E. DeLong,et al. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. , 1988, Biometrics.
[6] Emilie Niaf,et al. Influence of imaging and histological factors on prostate cancer detection and localisation on multiparametric MRI: a prospective study , 2013, European Radiology.
[7] Kirsten L. Greene,et al. Outcomes of active surveillance for men with intermediate-risk prostate cancer. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[8] H. Rusinek,et al. Whole‐lesion apparent diffusion coefficient metrics as a marker of percentage Gleason 4 component within Gleason 7 prostate cancer at radical prostatectomy , 2015, Journal of magnetic resonance imaging : JMRI.
[9] Ian H. Witten,et al. Data mining: practical machine learning tools and techniques, 3rd Edition , 1999 .
[10] W. Shabana,et al. Prostatic ductal adenocarcinoma: an aggressive tumour variant unrecognized on T2 weighted magnetic resonance imaging (MRI) , 2014, European Radiology.
[11] Stephan E Maier,et al. Multiparametric MRI of prostate cancer: An update on state‐of‐the‐art techniques and their performance in detecting and localizing prostate cancer , 2013, Journal of magnetic resonance imaging : JMRI.
[12] N. Schieda,et al. Assessing the utilization of functional imaging in multiparametric prostate MRI in routine clinical practice. , 2015, Clinical radiology.
[13] Yousef Mazaheri,et al. Prostate cancer aggressiveness: assessment with whole-lesion histogram analysis of the apparent diffusion coefficient. , 2014, Radiology.
[14] T. Stamey,et al. Relationship between systematic biopsies and histological features of 222 radical prostatectomy specimens: lack of prediction of tumor significance for men with nonpalpable prostate cancer. , 2001, The Journal of urology.
[15] M. Stasi,et al. Texture features on T2-weighted magnetic resonance imaging: new potential biomarkers for prostate cancer aggressiveness , 2015, Physics in medicine and biology.
[16] Thomas Wiegel,et al. EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease. , 2011, European urology.
[17] A. Hoznek,et al. Patient selection and pathological outcomes using currently available active surveillance criteria , 2013, BJU international.
[18] Baris Turkbey,et al. Correlation of magnetic resonance imaging tumor volume with histopathology. , 2012, The Journal of urology.
[19] A. Evans,et al. Active surveillance for the management of localized prostate cancer: Guideline recommendations. , 2015, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.
[20] J. Fütterer,et al. ESUR prostate MR guidelines 2012 , 2012, European Radiology.
[21] Linda M. Johnson,et al. The Role of MRI in Prostate Cancer Active Surveillance , 2014, BioMed research international.
[22] L. Egevad,et al. A Contemporary Prostate Cancer Grading System: A Validated Alternative to the Gleason Score. , 2016, European urology.
[23] Baris Turkbey,et al. Comparison of endorectal coil and nonendorectal coil T2W and diffusion‐weighted MRI at 3 Tesla for localizing prostate cancer: Correlation with whole‐mount histopathology , 2014, Journal of magnetic resonance imaging : JMRI.
[24] P. Choyke,et al. Accuracy of multiparametric magnetic resonance imaging in confirming eligibility for active surveillance for men with prostate cancer , 2013, Cancer.
[25] Jurgen J Fütterer,et al. Accuracy of multiparametric MRI for prostate cancer detection: a meta-analysis. , 2014, AJR. American journal of roentgenology.
[26] Deanna L Langer,et al. Intermixed normal tissue within prostate cancer: effect on MR imaging measurements of apparent diffusion coefficient and T2--sparse versus dense cancers. , 2008, Radiology.
[27] R. V. D. van den Bergh,et al. Outcomes of initially expectantly managed patients with low or intermediate risk screen‐detected localized prostate cancer , 2012, BJU international.
[28] M. Rubin,et al. Consensus statement with recommendations on active surveillance inclusion criteria and definition of progression in men with localized prostate cancer: the critical role of the pathologist , 2014, Virchows Archiv.
[29] J. Witjes,et al. Use of the Prostate Imaging Reporting and Data System (PI-RADS) for Prostate Cancer Detection with Multiparametric Magnetic Resonance Imaging: A Diagnostic Meta-analysis. , 2015, European urology.
[30] Chen Jie,et al. The value of diffusion-weighted imaging in the detection of prostate cancer: a meta-analysis , 2014, European Radiology.
[31] G. Cron,et al. Multi‐parametric (mp) MRI of prostatic ductal adenocarcinoma , 2015, Journal of magnetic resonance imaging : JMRI.
[32] D. Brizel,et al. National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology , 2012 .
[33] Baris Turkbey,et al. Magnetic resonance imaging/ultrasound-fusion biopsy significantly upgrades prostate cancer versus systematic 12-core transrectal ultrasound biopsy. , 2013, European urology.
[34] Amita Shukla-Dave,et al. Role of MRI in prostate cancer detection , 2014, NMR in biomedicine.
[35] Chih-Jen Lin,et al. LIBSVM: A library for support vector machines , 2011, TIST.
[36] L. Klotz,et al. Active surveillance for clinically localized prostate cancer––A systematic review , 2014, Journal of Surgical Oncology.
[37] W. Shabana,et al. Does a cleansing enema improve image quality of 3T surface coil multiparametric prostate MRI? , 2015, Journal of magnetic resonance imaging : JMRI.
[38] H. Hricak,et al. Multiparametric 3T MRI for the prediction of pathological downgrading after radical prostatectomy in patients with biopsy-proven Gleason score 3 + 4 prostate cancer , 2014, European Radiology.
[39] G. Collewet,et al. Influence of MRI acquisition protocols and image intensity normalization methods on texture classification. , 2004, Magnetic resonance imaging.
[40] Mary M. Galloway,et al. Texture analysis using gray level run lengths , 1974 .
[41] Baris Turkbey,et al. Prostate cancer: can multiparametric MR imaging help identify patients who are candidates for active surveillance? , 2013, Radiology.
[42] Yousef Mazaheri,et al. Diffusion-weighted endorectal MR imaging at 3 T for prostate cancer: tumor detection and assessment of aggressiveness. , 2011, Radiology.
[43] Lawrence D. True,et al. The critical role of the pathologist in determining eligibility for active surveillance as a management option in patients with prostate cancer: consensus statement with recommendations supported by the College of American Pathologists, International Society of Urological Pathology, Association of D , 2014, Archives of pathology & laboratory medicine.
[44] Thomas Wiegel,et al. Guidelines on Prostate Cancer , 2013 .